Pure Global
NCT06407908

Urdu Translation Of Pediatric Version Of Eating Assessment Tool

Urdu Translation AND Psychoprometric Properties Of Pediatric Version Of Eating Assessment Tool
Riphah International University·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cerebral Palsy
Study type
Observational
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
May 15, 2024
End date
Jun 28, 2024
Enrollment
42 participants
Primary outcome

Pediatric Version of the Eating Assessment Tool (Pedi-EAT-10)

Summary

Dysphagia encompasses challenges encountered during the many stages of swallowing, including
 the oral phase, commencement of the swallow, pharyngeal phase, and esophageal phase. The
 incidence of pediatric dysphagia is on the rise as a result of advancements in medical care
 that have led to higher survival rates among infants born prematurely, with low birth weight,
 and with complex medical disorders. The Eating Assessment Tool (EAT-10), consisting of 10
 items, was first developed for infant patients.
 
 (PEDI-EAT-10) will be translated into Urdu language by using forward backwards translation
 method. Two bilingual speakers expert in both Urdu and English languages will assist the
 researcher in the forward translation of the tool. This final translated version will be then
 tested for validity and reliability on all participants of the study. The psychometric
 properties of the tool will be assessed including reliability, internal consistency, and item
 discrimination.

ICD-10 classifications
Cerebral palsyOther cerebral palsyCerebral palsy, unspecifiedDyskinetic cerebral palsyAtaxic cerebral palsy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06407908
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06407908 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 42 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.